Eli Lilly
LLY
LLY
1,365 hedge funds and large institutions have $71.1B invested in Eli Lilly in 2018 Q2 according to their latest regulatory filings, with 121 funds opening new positions, 426 increasing their positions, 543 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,365
Holders Change
+35
Holders Change %
+2.63%
% of All Funds
31.29%
Holding in Top 10
23
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.55%
% of All Funds
0.53%
New
121
Increased
426
Reduced
543
Closed
78
Calls
$368M
Puts
$392M
Net Calls
-$24.4M
Net Calls Change
+$45.2M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$442M |
| 2 |
JPMorgan Chase & Co
New York
|
+$293M |
| 3 |
Morgan Stanley
New York
|
+$105M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$105M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$91.9M |
Top Sellers
| 1 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$358M |
| 2 |
Renaissance Technologies
New York
|
-$279M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$259M |
| 4 |
Goldman Sachs
New York
|
-$142M |
| 5 |
Two Sigma Investments
New York
|
-$107M |
